Skip to main content
. 2017 Aug 30;7:9932. doi: 10.1038/s41598-017-09494-6

Figure 7.

Figure 7

The deleterious effects mediated via the repression of activator E2Fs can be reversed within a limited time frame. (a) Histogram of total numbers of erythrocytes, leukocytes, and platelets in in E2f1 −/−; E2f2 −/−; E2f3 TRE/TRE control (n = 8) and E2f1 −/−; E2f2 −/−; E2f3 TRE/TRE; β-actin-tTS mice following withdrawal of 100 mg/L tetracycline for 2 weeks (−2, n = 3), or following removal of tetracycline for 2 weeks followed by re-administration of tetracycline for the indicated number of weeks (−2/+1, n = 3(erythrocytes), n = 2(leukocytes, platelets)) and (−2/+2, n = 5(erythrocytes, platelets), n = 4(leukocytes)), respectively. Error bars, s.e.m. Two-tailed t-test; -2weeks vs. −2/+2weeks, **P = 0.001(leukocytes), 0.04*(platelets). (b) Quantification of differentiated intestinal cells per villus or crypt (stained as in Fig. 5D) in E2f1 −/−; E2f2 −/−; E2f3 TRE/TRE control (n = 10(enteroendocrine, goblet), n = 9(Paneth)) and E2f1 −/−; E2f2 −/−; E2f3 TRE/TRE; β-actin-tTS mice following tetracycline removal for 2 weeks (-2, n = 2(enteroendocrine), n = 3 (goblet, Paneth)), or following removal of tetracycline for 2 weeks followed by re-administration of tetracycline for the indicated number of weeks (−2/+1, n = 2), (−2/+2, n = 5). Two-tailed t-test; -2weeks vs. −2/+2weeks, *P = 0.04 (goblet), 0.02*(Paneth).